'The Liver Meeting 2012', the 63rd annual meeting of the American Association for the Study of Liver Diseases (AASLD), took place in Boston, USA, 9-13th November 2012.

Conference highlights

Telaprevir: study results

Final study results show telaprevir is safe and effective for HIV/HCV co-infected people.

Interferon-free combination

Abbott interferon-free combination 'promising' in harder-to-treat patients with hepatitis C.

Boceprevir: managing anaemia

Reducing ribavirin and adding EPO are both good anaemia management strategies for people taking boceprevir

aidsmap news from AASLD 2012

← First12Next →

Editors' picks from other sources

News bulletins

Sign up for our email bulletins

Official conference website

Find out more about the conference and view the programme on the official conference website.

Visit the conference website >